Literature DB >> 25542966

Response.

Julia C Gage1, Mark Schiffman2, Hormuzd A Katki2, Philip E Castle2, Barbara Fetterman2, Nicolas Wentzensen2, Nancy E Poitras2, Thomas Lorey2, Li C Cheung2, Walter K Kinney2.   

Abstract

Mesh：

Year:  2014        PMID： 25542966      PMCID： PMC4334836          DOI： 10.1093/jnci/dju390

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  8 in total

1.  Neither one-time negative screening tests nor negative colposcopy provides absolute reassurance against cervical cancer.

Authors:  Philip E Castle; Ana C Rodríguez; Robert D Burk; Rolando Herrero; Allan Hildesheim; Diane Solomon; Mark E Sherman; Jose Jeronimo; Mario Alfaro; Jorge Morales; Diego Guillén; Martha L Hutchinson; Sholom Wacholder; Mark Schiffman
Journal:  Int J Cancer       Date:  2009-10-01       Impact factor: 7.396

2.  American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.

Authors:  Debbie Saslow; Diane Solomon; Herschel W Lawson; Maureen Killackey; Shalini L Kulasingam; Joanna Cain; Francisco A R Garcia; Ann T Moriarty; Alan G Waxman; David C Wilbur; Nicolas Wentzensen; Levi S Downs; Mark Spitzer; Anna-Barbara Moscicki; Eduardo L Franco; Mark H Stoler; Mark Schiffman; Philip E Castle; Evan R Myers
Journal:  CA Cancer J Clin       Date:  2012-03-14       Impact factor: 508.702

3.  ACOG Practice Bulletin Number 131: Screening for cervical cancer.

Authors: 
Journal:  Obstet Gynecol       Date:  2012-11       Impact factor: 7.661

4.  Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.

Authors:  Philip E Castle; Mark H Stoler; Thomas C Wright; Abha Sharma; Teresa L Wright; Catherine M Behrens
Journal:  Lancet Oncol       Date:  2011-08-22       Impact factor: 41.316

Review 5.  From differences in means between cases and controls to risk stratification: a business plan for biomarker development.

Authors:  Nicolas Wentzensen; Sholom Wacholder
Journal:  Cancer Discov       Date:  2013-01-08       Impact factor: 39.397

6.  Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement.

Authors:  Virginia A Moyer
Journal:  Ann Intern Med       Date:  2012-06-19       Impact factor: 25.391

Review 7.  The expected impact of HPV vaccination on the accuracy of cervical cancer screening: the need for a paradigm change.

Authors:  Eduardo L Franco; Salaheddin M Mahmud; Joseph Tota; Alex Ferenczy; François Coutlée
Journal:  Arch Med Res       Date:  2009-07-25       Impact factor: 2.235

8.  Impact of human papillomavirus vaccination on cervical cytology screening, colposcopy, and treatment.

Authors:  Ana Cecilia Rodríguez; Diane Solomon; Rolando Herrero; Allan Hildesheim; Paula González; Sholom Wacholder; Carolina Porras; Silvia Jiménez; Mark Schiffman
Journal:  Am J Epidemiol       Date:  2013-07-10       Impact factor: 4.897
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.